SCHEDULE: Quipt Home Medical to be Acquired for $3.65/Share Cash

Quipt Home Medical Corp. will be acquired by REM Aggregator, LLC and 1567208 B.C. Ltd. for $3.65 per share in cash via a plan of arrangement.

Summary

• Quipt Home Medical Corp. (Quipt) will be acquired by 1567208 B.C. Ltd. (Purchaser) and REM Aggregator, LLC for $3.65 per share in cash.
• The acquisition will be executed through a plan of arrangement.
• Forager Fund, L.P., a significant shareholder holding 9.5% of Quipt's common stock (4,199,562 shares), has entered into a Voting and Support Agreement.
• Under the agreement, Forager Fund, L.P. commits to vote all its Subject Shares in favor of the Arrangement and against any competing acquisition proposals.
• Quipt's directors, Gregory Crawford and Hardik Mehta, who collectively hold approximately 11.4% of outstanding shares, have also entered into similar voting agreements.
• The transaction is expected to close in the first half of 2026.
• Post-acquisition, Quipt's common shares will be delisted from Nasdaq and TSX, and deregistered under the Securities Exchange Act of 1934.

Sentiment

Score: 7

Explanation: The definitive cash acquisition provides certainty and a premium for shareholders, supported by key stakeholders. While delisting removes public access, the fixed cash value is generally positive for current investors, assuming the offer price is attractive.

Positives

• Shareholders will receive a fixed cash consideration of $3.65 per share, providing certainty of value.
• Significant shareholders, including Forager Fund, L.P. (9.5% stake) and two directors (11.4% combined stake), have committed to support the Arrangement, increasing the likelihood of approval.
• The transaction is backed by equity commitments from Kingswood Capital Management, L.P., ensuring funding for the acquisition.

Negatives

• Quipt's common shares will be delisted from The Nasdaq Capital Market and the Toronto Stock Exchange, and deregistered, removing public trading access.
• The company will cease to be a Canadian "reporting issuer."
• The Voting and Support Agreement restricts the Securityholder from transferring Subject Securities or soliciting alternative acquisition proposals, limiting potential for higher offers from other parties.

Risks

• Failure to obtain required approvals, including 66 2/3% shareholder approval (and simple majority excluding certain shareholders if required by Canadian law) and court approval.
• Dissent rights being exercised by more than 10% of issued and outstanding shares could prevent the closing.
• The occurrence of a Material Adverse Effect with respect to Quipt.
• Failure to receive approval or expiration of the waiting period under the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976.
• Termination of the Arrangement Agreement under specified events, which could result in a $6,950,000 termination fee payable by Quipt.

Future Outlook

The parties expect to close the Arrangement in the first half of 2026, subject to various conditions including shareholder and court approvals, regulatory clearances, and the absence of a Material Adverse Effect. Following the acquisition, Quipt's shares will be delisted and deregistered.

Management Comments

• Quipt's directors, Gregory Crawford (CEO) and Hardik Mehta, who collectively hold approximately 11.4% of the Issuer's outstanding shares, entered into similar voting and support agreements.
• The Securityholder acknowledges that Quipt and Purchaser are entering into the Arrangement Agreement in reliance upon the Securityholder's execution, delivery, and performance of the Voting and Support Agreement.

Industry Context

This acquisition represents a consolidation event within the home medical equipment sector, with a private equity firm (Kingswood Capital Management) taking a publicly traded company private. This trend often reflects a desire for operational efficiencies, strategic repositioning away from public market scrutiny, or leveraging specific market opportunities.

Corporate Governance

Related Party Transactions

• Forager Fund, L.P. (a significant shareholder) entered into a Voting and Support Agreement with the Purchaser and Quipt.
• Quipt directors Gregory Crawford and Hardik Mehta also entered into similar voting and support agreements.
• Forager Capital Management, LLC (general partner of Forager Fund, L.P.) will contribute cash to REM Aggregator for a non-controlling equity interest, and will have representation on REM Aggregator's board.

Stakeholder Impact

• Shareholders: Will receive $3.65 cash per share, providing liquidity and a definitive return. Those holding shares for long-term growth in a public company will lose that opportunity.
• Employees: Not directly addressed, but acquisitions can lead to organizational restructuring.
• Customers: Not directly addressed, but a change in ownership could impact service offerings or focus.
• Creditors: Not directly addressed, but the acquisition is funded by equity commitments, suggesting a stable financial backing for the transaction.

Next Steps

• Quipt shareholders will hold a special meeting to vote on the Arrangement, requiring 66 2/3% approval (and potentially a simple majority excluding certain shareholders).
• Obtain court approval for the Arrangement.
• Satisfy regulatory approvals, including the U.S. Hart-Scott-Rodino Antitrust Improvements Act of 1976.
• Complete the acquisition in the first half of 2026.
• Delist Quipt's common shares from Nasdaq and TSX.
• Deregister Quipt under the Securities Exchange Act of 1934.
• Quipt will cease to be a Canadian "reporting issuer."

Key Dates

Recommendation

The filing announces a definitive cash acquisition at $3.65 per share. For investors, the primary action is to hold shares until the transaction closes to receive the cash consideration, or sell in the market if the current price is close to the offer price and liquidity is desired sooner. Given the voting support from significant shareholders and management, and the equity commitment, the likelihood of the deal closing appears high, making 'hold' a reasonable recommendation to capture the acquisition premium.

Keywords

Quipt Home Medical, Acquisition, Merger, Cash Offer, Shareholder Vote, SEC Filing, Schedule 13D, Voting Agreement, Healthcare, Medical Devices, Home Medical Equipment, Kingswood Capital, Forager Fund